JP2002502827A - ヒト免疫不全ウイルスに対する生ワクチン - Google Patents

ヒト免疫不全ウイルスに対する生ワクチン

Info

Publication number
JP2002502827A
JP2002502827A JP2000530232A JP2000530232A JP2002502827A JP 2002502827 A JP2002502827 A JP 2002502827A JP 2000530232 A JP2000530232 A JP 2000530232A JP 2000530232 A JP2000530232 A JP 2000530232A JP 2002502827 A JP2002502827 A JP 2002502827A
Authority
JP
Japan
Prior art keywords
hiv
reverse transcriptase
protein
vaccine
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000530232A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002502827A5 (enExample
Inventor
バーネット，マリー，スーザン
キットー，ジョージ，バリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Publication of JP2002502827A publication Critical patent/JP2002502827A/ja
Publication of JP2002502827A5 publication Critical patent/JP2002502827A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • External Artificial Organs (AREA)
JP2000530232A 1998-02-06 1999-02-04 ヒト免疫不全ウイルスに対する生ワクチン Withdrawn JP2002502827A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7394398P 1998-02-06 1998-02-06
US60/073,943 1998-02-06
PCT/US1999/002503 WO1999039735A1 (en) 1998-02-06 1999-02-04 Live vaccine for human immunodeficiency virus

Publications (2)

Publication Number Publication Date
JP2002502827A true JP2002502827A (ja) 2002-01-29
JP2002502827A5 JP2002502827A5 (enExample) 2006-03-23

Family

ID=22116747

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000530232A Withdrawn JP2002502827A (ja) 1998-02-06 1999-02-04 ヒト免疫不全ウイルスに対する生ワクチン

Country Status (13)

Country Link
EP (1) EP1061950B1 (enExample)
JP (1) JP2002502827A (enExample)
KR (1) KR20010040618A (enExample)
CN (1) CN1216640C (enExample)
AT (1) ATE287727T1 (enExample)
AU (1) AU744730B2 (enExample)
CA (1) CA2320489A1 (enExample)
DE (1) DE69923439D1 (enExample)
IL (1) IL137680A0 (enExample)
NZ (1) NZ506093A (enExample)
RU (1) RU2223784C2 (enExample)
WO (1) WO1999039735A1 (enExample)
ZA (1) ZA99912B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023516420A (ja) * 2020-03-05 2023-04-19 ユニヴァーシティー オブ メリーランド バルチモア がんタンパク質抗原を発現するように操作された生チフス菌ベクターおよびその使用方法
WO2025063261A1 (ja) * 2023-09-22 2025-03-27 塩野義製薬株式会社 ウイルス由来タンパク質をコードするポリヌクレオチド

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802426B1 (fr) 1999-12-15 2004-04-02 Neovacs Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires
AU8640501A (en) * 2000-07-31 2002-02-13 Univ Yale Innate immune system-directed vaccines
KR100447530B1 (ko) * 2001-08-14 2004-09-08 한국과학기술원 ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법
EP1670505B1 (en) 2003-09-18 2012-11-14 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Dna promoters and anthrax vaccines
ES2555544T3 (es) 2006-03-07 2016-01-04 Vaxinnate Corporation Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
CN101195823B (zh) * 2007-11-20 2010-06-02 华东理工大学 细菌表面展示系统、方法及应用
CN109207417A (zh) * 2018-09-19 2019-01-15 湖北省农业科学院畜牧兽医研究所 鸡白痢-j亚群禽白血病双重平板凝集抗原及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757013A (en) * 1983-07-25 1988-07-12 The Research Foundation Of State University Of New York Cloning vehicles for polypeptide expression in microbial hosts
AU9179891A (en) * 1990-12-19 1992-07-22 Epitope, Inc. Hiv reverse transcriptase vaccine
JP3100005B2 (ja) * 1992-07-28 2000-10-16 雪印乳業株式会社 ヒト免疫不全ウィルス感染・増殖抑制剤
AU3958895A (en) * 1994-10-18 1996-05-06 Board Of Regents, The University Of Texas System Membrane expression of heterologous genes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023516420A (ja) * 2020-03-05 2023-04-19 ユニヴァーシティー オブ メリーランド バルチモア がんタンパク質抗原を発現するように操作された生チフス菌ベクターおよびその使用方法
WO2025063261A1 (ja) * 2023-09-22 2025-03-27 塩野義製薬株式会社 ウイルス由来タンパク質をコードするポリヌクレオチド

Also Published As

Publication number Publication date
DE69923439D1 (de) 2005-03-03
ATE287727T1 (de) 2005-02-15
RU2223784C2 (ru) 2004-02-20
AU744730B2 (en) 2002-02-28
CA2320489A1 (en) 1999-08-12
IL137680A0 (en) 2001-10-31
KR20010040618A (ko) 2001-05-15
AU3180199A (en) 1999-08-23
NZ506093A (en) 2003-08-29
EP1061950A1 (en) 2000-12-27
CN1216640C (zh) 2005-08-31
WO1999039735A9 (en) 2000-01-27
EP1061950A4 (en) 2001-12-05
EP1061950B1 (en) 2005-01-26
WO1999039735A1 (en) 1999-08-12
CN1290175A (zh) 2001-04-04
ZA99912B (en) 2000-08-07

Similar Documents

Publication Publication Date Title
RU2201253C2 (ru) Микрофлюидизированная композиция для индукции специфичного цитотоксического т-лимфоцитного иммунного ответа и ее использование для лечения заболеваний
CA2102918C (en) Genetic vaccine for immunodeficiency viruses
JP4472250B2 (ja) 高発現可能遺伝子
Niikura et al. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes
CN101969990B (zh) 增强针对艾美球虫属的免疫反应的组合物和方法
JP5502757B2 (ja) ワクチンとしてのキメラｈｉｖ融合タンパク質
US7262270B2 (en) Fusion protein construct and method for inducing HIV-specific serum IgG and secretory IgA antibodies in-vivo
JP2003518931A (ja) Ｈｉｖに対する免疫応答における改善、または免疫応答に関する改善
CN1156966A (zh) 用于乳头状瘤病毒的多核苷酸疫苗
MXPA06004567A (es) Metodo y composicion inmunologica para desarrollar una vacuna basada en partes de la proteina matriz del vih.
JP2000505299A (ja) 合成ｈｉｖ遺伝子
CN1252075A (zh) 合成的hiv gag基因
WO1992010513A1 (en) Subunit papillomavirus vaccine and peptides for use therein
CN114480463B (zh) 一种减毒沙门氏菌分泌表达rbd结构域蛋白的新型冠状病毒疫苗抗原递呈系统及其应用
EP1061950B1 (en) Live vaccine for human immunodeficiency virus
US20090162388A1 (en) Fish Vaccine
JP2002509421A (ja) グラム陽性菌の表面上のハイブリッド表面タンパク質の供給及び発現
JP2013530707A (ja) 尿路感染症（ｕｔｉ）ワクチン
CN100393878C (zh) 疫苗
US7189402B1 (en) Live vaccine for human immunodeficiency virus
JP4411213B2 (ja) ネコ白血病ウィルスによるネコ感染症のようなオンコウィルス感染症に対するワクチン
JP4535874B2 (ja) 肝炎に対するバクテリオファージを介する免疫
EP1007687A1 (en) Fiv vaccine
WO2002079240A2 (en) Intimins for the prevention or treatment of infections: i
AU660954B2 (en) Subunit papillomavirus vaccine and peptides for use therein

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060125

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060125

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060125

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20081216